Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00508014 · ClinicalTrials.gov registry record · NA
Assessing the Effectiveness of Concurrent Peer Review for Patients With Cardiovascular Disease and Diabetes
A NA study of Cardiovascular Diseases, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 727
- Enrollment target
- 1
- Study location
NCT00508014: Completed NA study of Cardiovascular Diseases, sponsored by University of Rochester.
NCT00508014 is a NA study of Cardiovascular Diseases that has completed, run by University of Rochester. The registered enrollment target is 727 participants, below the 26,972-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00508014, a NA study of Cardiovascular Diseases, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 727 participants
- Enrollment target
- 1
- Study location
Study Summary
We will assess the impact of concurrent peer review vists on blood pressure, cholesterol and diabetes control. Concurrent peer review (CPR) visits refer to special offic visits by patients to a clinician (physician, nurse practitioner, or physician assistant) other than than their primary care provider that are specifically designed to improve care for diabetes and cardiovascular disease.
Conditions Studied
Interventions
- OTHER Usual Care
- BEHAVIORAL Concurrent Peer Review visit
Study Locations (1)
New York
- Westside Health Services, Inc - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 727 participants |
| Start Date | 2006-12 |
| Est. Completion | 2010-06 |
| Phase | NA |
What the finished NCT00508014 record still lists
NCT00508014 is an interventional study that assigns participants to a tested intervention. The registered 727 participants enrollment target is mid-sized for trials with a published cap, below the 26,972-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Cardiovascular Diseases appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.
NCT00508014 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00508014 about?
NCT00508014 is a clinical study titled "Assessing the Effectiveness of Concurrent Peer Review for Patients With Cardiovascular Disease and Diabetes". We will assess the impact of concurrent peer review vists on blood pressure, cholesterol and diabetes control. Concurrent peer review (CPR) visits refer to special offic visits by patients to a clinician (physician, nurse practitioner, or physician assistant) other than than their primary care provi...
What is the current status of trial NCT00508014?
This trial is currently completed. It is a NA study. The enrollment target is 727 participants. The study started on 2006-12. Estimated completion is 2010-06.
What conditions does trial NCT00508014 study?
This clinical trial studies the following conditions: Cardiovascular Diseases.
What interventions are being tested in trial NCT00508014?
The interventions under investigation include: Usual Care (OTHER), Concurrent Peer Review visit (BEHAVIORAL).
Who is sponsoring clinical trial NCT00508014?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00508014 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00508014's enrollment target sits among peer trials
727 76th of 300 higher than 225 of 300 other Cardiovascular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05065216 · 728 participants · Phase 2
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
- NCT05739123 · 728 participants
Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring
- NCT06433765 · 728 participants
A Study Evaluating the Effect of BRIUMVI® (Ublituximab) on Pregnancy and Infant Outcomes in Participants With Multiple Sclerosis (MS)
- NCT06660342 · 728 participants
A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia